Zealand Pharma

Showing 2 posts of 2 posts found.

Zealand’s Zegalogue treatment for hypoglycemia approved by FDA

March 23, 2021
Manufacturing and Production FDA, Zealand Pharma, Zegalogue

The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in patients with diabetes.

zealand_pharma_hanne_leth_hillman

Hanne Leth Hillman joins Zealand Pharma

January 13, 2011
Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications

Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …

The Gateway to Local Adoption Series

Latest content